Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
75,196
-8,371
-10% -$219K 0.26% 88
2026
Q1
$2.35M Buy
83,567
+4,650
+6% +$124K 0.38% 61
2025
Q4
$1.97M Buy
78,917
+17,081
+28% +$431K 0.31% 72
2025
Q3
$1.58M Buy
61,836
+2,522
+4% +$62.2K 0.22% 89
2025
Q2
$1.44M Buy
59,314
+17,250
+41% +$402K 0.2% 99
2025
Q1
$1.07M Buy
42,064
+315
+0.8% +$8.24K 0.19% 116
2024
Q4
$1.11M Buy
41,749
+4,400
+12% +$119K 0.2% 111
2024
Q3
$1.08M Sell
37,349
-33
-0.1% -$963 0.19% 118
2024
Q2
$1.05M Sell
37,382
-4,448
-11% -$122K 0.21% 103
2024
Q1
$1.16M Buy
41,830
+7,400
+21% +$205K 0.24% 100
2023
Q4
$991K Sell
34,430
-18,632
-35% -$563K 0.22% 110
2023
Q3
$1.76M Sell
53,062
-1,455
-3% -$51.5K 0.44% 59
2023
Q2
$2M Sell
54,517
-1,560
-3% -$60.7K 0.48% 51
2023
Q1
$2.29M Sell
56,077
-18,188
-24% -$786K 0.57% 45
2022
Q4
$3.81M Sell
74,265
-9,373
-11% -$449K 0.95% 20
2022
Q3
$3.66M Sell
83,638
-2,766
-3% -$134K 0.95% 21
2022
Q2
$4.53M Buy
86,404
+1,831
+2% +$93.3K 1.14% 14
2022
Q1
$4.38M Sell
84,573
-3,405
-4% -$177K 0.94% 23
2021
Q4
$5.2M Buy
87,978
+7,190
+9% +$356K 1.03% 14
2021
Q3
$3.47M Buy
80,788
+6,656
+9% +$295K 0.76% 32
2021
Q2
$2.9M Buy
74,132
+12,413
+20% +$483K 0.69% 40
2021
Q1
$2.24M Buy
61,719
+3,142
+5% +$112K 0.77% 43
2020
Q4
$2.16M Sell
58,577
-275
-0.5% -$10.1K 0.74% 42
2020
Q3
$2.05M Buy
58,852
+1,046
+2% +$36.7K 0.85% 35
2020
Q2
$1.79M Sell
57,806
-335
-0.6% -$11.4K 0.79% 37
2020
Q1
$1.8M Sell
58,141
-1,019
-2% -$34.7K 0.91% 32
2019
Q4
$2.2M Sell
59,160
-2,172
-4% -$77.4K 0.89% 35
2019
Q3
$2.09M Sell
61,332
-247
-0.4% -$8.98K 0.88% 34
2019
Q2
$2.53K Sell
61,579
-5,868
-9% -$233K 1.08% 31
2019
Q1
$2.72K Sell
67,447
-2,212
-3% -$88.6K 1.17% 27
2018
Q4
$2.88K Sell
69,659
-1,111
-2% -$46.1K 1.37% 25
2018
Q3
$2.96M Buy
70,770
+812
+1% +$31.3K 1.18% 27
2018
Q2
$2.41M Sell
69,958
-726
-1% -$24.8K 1.03% 35
2018
Q1
$2.38M Sell
70,684
-1,021
-1% -$35.1K 1.02% 36
2017
Q4
$2.46M Hold
71,705
0.98% 39
2017
Q3
$2.43K Buy
71,705
+1,338
+2% +$43K 1.02% 37
2017
Q2
$2.24K Sell
70,367
-980
-1% -$30.9K 1% 38
2017
Q1
$2.32K Sell
71,347
-1,637
-2% -$51.6K 1.02% 34
2016
Q4
$2.25M Sell
72,984
-362
-0.5% -$11.1K 0.98% 41
2016
Q3
$2.36M Sell
73,346
-1,176
-2% -$39.3K 1.03% 32
2016
Q2
$2.49M Hold
74,522
1.02% 31
2016
Q1
$2.1M Sell
74,522
-6,903
-8% -$197K 0.87% 42
2015
Q4
$2.49M Sell
81,425
-4,948
-6% -$156K 0.97% 30
2015
Q3
$2.57M Sell
86,373
-4,641
-5% -$149K 0.99% 31
2015
Q2
$2.9M Sell
91,014
-3,233
-3% -$105K 1.02% 29
2015
Q1
$3.11M Buy
+94,247
New +$3M 1.07% 28

Other funds holding PFE

Chicago Trust's PFE Position: Q2 2026 in Review

Chicago Trust reduced its Pfizer (PFE) stake by 10% in Q2 2026, selling an estimated $219K and leaving 75,196 shares worth $1.81M. The position accounts for 0.26% of the portfolio, ranked #88.

Chicago Trust first reported a position in PFE in Q1 2015 and has held it in 46 quarters since. The position peaked at $5.2M in Q4 2021. 568 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Chicago Trust held 75,196 shares of Pfizer worth $1.81M as of Q2 2026.
  • Chicago Trust sold 8,371 Pfizer shares in Q2 2026, an estimated $219K.
  • Pfizer made up 0.26% of Chicago Trust's portfolio in Q2 2026, its #88 holding.
  • Chicago Trust first reported a position in Pfizer in Q1 2015 and has held it in 46 quarters since.
  • Chicago Trust's Pfizer position peaked at $5.2M in Q4 2021.
  • 568 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.